Last week we enjoyed our annual UK summer party in London. Thanks to everyone for making it so much fun—we were even lucky enough to get some good weather!
Compass Pathways’ Post
More Relevant Posts
-
Every 40 seconds, someone dies from suicide; tens of millions more live with mental health conditions for which there is no good standard of care. Treatment-resistant depression (TRD) is one of these conditions. A lesser-known subset of major depressive disorder, TRD is believed to affect more than 100 million people around the world*. People living with TRD have tried at least two different treatments within a depressive episode without success, with the chance of response decreasing with every subsequent treatment. More needs to be done to change this. This Mental Health Awareness Month, we hear real stories from people living with TRD. *Reference: McIntyre RS, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023 Oct;22(3):394-412.
-
Some of the most difficult-to-treat mental health conditions, including treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD) and eating disorders, have very few treatment options. However, steps are being taken to a bring about a paradigm shift that could help to change the future of mental health for the millions of people who urgently need new options. Our CEO, Kabir Nath, explores this need for new treatments in the mental health space in the Spring edition of Pharmafile. Read more below.
-
It’s great to see that the Centre for Mental Health Research and Innovation, a pioneering collaboration between Compass, King's College London, and South London and Maudsley NHS Foundation Trust, has won the Refurbishment Project of the Year at this year’s Design in Mental Health Awards. Congratulations to Arcadis and thank you for all of your work in making this happen.
It was really wonderful to receive an award for 5 Windsor Walk - Project of the Year for Refurbishment at the Design in Mental Health Awards on Thursday. https://lnkd.in/gKAcftCH The project is one of the first standalone facilities in the UK dedicated to accelerating psychedelic research in the form of Psilocybin. A hugely innovative new model of care. Compass Pathways have been a fantastic client to work with over the past few years - pushing the boundaries in how we address mental health, https://lnkd.in/gxMsCC_A Also recognised in this award are the client partners South London and Maudsley NHS Foundation Trust, and King's College London. Their years of research in this field is so impressive. (A shout out must go to Contractors CUFFE CONSTRUCTION LIMITED and WT PARTNERSHIP-GROUP too) We look forward to working with the team again one day soon! Congratulations everyone! 🎉 #Arcadis #Compasspathways
-
-
Everyone deserves to live proudly as themselves, free of fear and stigma and the challenges they can bring. That’s why this year, to recognise Pride, our Compass team is fundraising to support the Trevor Project, an organisation whose mission is to end suicide among LGBTQ+ young people. You can read more about the Trevor Project here: https://lnkd.in/gSG_Ckx
-
Post-traumatic stress disorder affects millions of people around the world. By raising awareness, we can make it easier for people to seek support. #PTSDAwarenessDay
-
We’re delighted to announce that Lori Englebert will be joining Compass as our new Chief Commercial Officer. Lori brings extensive experience in global pharmaceuticals and scaling commercial organisations. Together with Michael Gold and Teri Loxam, both of whom also recently joined Compass, as well as the existing members of the executive team, we have experienced leadership to lead us through our phase 3 programme and beyond. Read our press release: https://lnkd.in/ePay_XUM
